Teva Pharmaceuticals - Wikipedia
Perrigo rejects Mylan, opening door for Teva - MarketWatch
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Teva Pharmaceutical Industries Stock Gives Every Indication Of Being Modestly Undervalued
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Mylan tries to fend off Teva with bigger bid for Perrigo - MarketWatch
Teva's stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more - MarketWatch
Israel stocks tick lower; Teva, Itamar in focus - MarketWatch
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid crisis - MarketWatch
Teva Stock Climbs as Earnings Hint at Turnaround | Barron's
Teva Pharmaceutical Industries Stock Jumps on a Rare Bullish View | Barron's
Israel stocks rise, led by Teva, ICL - MarketWatch
Market News
Teva Pharmaceutical Industries Ltd. (TEVA) Moves 7.5% Higher: Will This Strength Last?
Israel stocks up; FTC eyes Teva-Cephalon deal - MarketWatch
Opinion: Multinationals learn the limits of being big - MarketWatch
Israel stocks rise as investors key on Teva, ICL - MarketWatch
Deckers racked up $2 billion in Ugg boots sales in record year; stock jumps 14% - MarketWatch
Three health-care deals today are paying huge premiums - MarketWatch
Teva Pharmaeutical Stock Gets Upgrade From Analyst | Barron's
Teva shares surge on corporate shake-up - MarketWatch
TEVA — TradingView
Teva stock drops on guidance, manufacturing problems - MarketWatch
Israel stocks at record; Biogen remarks cost Teva - MarketWatch
